Internal mammary artery grafting for coronary hypoperfusion in children

C Vuran1, P Simon, G Wollenek

  • 1Department of Cardiovascular Surgery, Baskent University, Istanbul, Turkey. canvuran@hotmail.com

Insights

Internal mammary artery bypass grafting is a safe and effective procedure for children experiencing coronary artery issues. This study shows no operative mortality and successful graft patency in pediatric patients.

Area of Science:

  • Pediatric Cardiac Surgery
  • Vascular Surgery
  • Cardiology

Background:

  • Pediatric coronary artery bypass is crucial for managing ischemic complications from Kawasaki disease, congenital anomalies, and iatrogenic issues.
  • Internal mammary artery (IMA) grafting is a potential revascularization strategy in pediatric patients.

Purpose of the Study:

  • To evaluate the outcomes of myocardial revascularization using the internal mammary artery in pediatric patients.
  • To assess the safety and efficacy of IMA bypass grafting in infants and children.

Main Methods:

  • Myocardial revascularization was performed in 6 pediatric patients using the internal mammary artery.
  • Patient ages ranged from 7 days to 10 years.
  • Outcomes were reviewed postoperatively.

Main Results:

  • No operative mortality was observed in the study cohort.
  • All coronary bypass grafts remained patent from 3 months to 3 years postoperatively.
  • No patients experienced recurrent angina or signs of myocardial ischemia.

Conclusions:

  • Internal mammary artery bypass grafting is a successful procedure in infants and children, yielding good clinical results.
  • While long-term patency and distal anastomosis growth require further investigation, historical data suggests favorable outcomes up to 25 years.
Abstract

Related Concept Videos